Cargando…
Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling
PPAR-δ agonists are known to enhance fatty acid metabolism, preserving glucose and physical endurance and are suggested as candidates for treating metabolic diseases. None have reached the clinic yet. Our Machine Learning algorithm called “Iterative Stochastic Elimination” (ISE) was applied to const...
Autores principales: | Da’adoosh, Benny, Marcus, David, Rayan, Anwar, King, Fred, Che, Jianwei, Goldblum, Amiram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355875/ https://www.ncbi.nlm.nih.gov/pubmed/30705343 http://dx.doi.org/10.1038/s41598-019-38508-8 |
Ejemplares similares
-
Computational design of substrate selective inhibition
por: Da’adoosh, Benny, et al.
Publicado: (2020) -
Candidate Therapeutics by Screening for Multitargeting Ligands: Combining the CB2 Receptor With CB1, PPARγ and 5-HT4 Receptors
por: El-Atawneh, Shayma, et al.
Publicado: (2022) -
Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes
por: Erlichman, Nofar, et al.
Publicado: (2022) -
Correction: Erlichman et al. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes. Cancers 2022, 14, 1042
por: Erlichman, Nofar, et al.
Publicado: (2022) -
Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding
por: Batista, Fernanda A. H., et al.
Publicado: (2012)